A rapid assessment of take-home naloxone provision during COVID-19 in Europe.
McDonald R, Eide D, Abel-Ollo K, Barnsdale L, Carter B, Clausen T, Day E, Fonseca F, Holmén E, Horsburgh K, Kelleher M, Kåberg M, Ladenhauf M, McAuley A, Metrebian N, Neale J, Parkin S, Ratcliffe K, Rintoul C, Smith J, Stifanoviciute V, Torrens M, Thiesen H, Strang J.
McDonald R, et al. Among authors: carter b.
Int J Drug Policy. 2022 Sep;107:103787. doi: 10.1016/j.drugpo.2022.103787. Epub 2022 Jul 1.
Int J Drug Policy. 2022.
PMID: 35849935
Free PMC article.